Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myeloid lineage cells evince distinct steady-state level of certain gene groups in dependence on hereditary angioedema severity. | Front Genet | 2023 | 37470035 | PubTator, text mining | PubMed |
| New Efforts to Demonstrate the Successful Use of TRH as a Therapeutic Agent. | Int J Mol Sci | 2023 | 37446225 | PubTator, text mining | PubMed |
| β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4. | Cell Death Dis | 2023 | 37443143 | PubTator, text mining | PubMed |
| Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome. | Front Genet | 2023 | 37434949 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity. | Nat Commun | 2023 | 37402735 | PubTator, text mining | PubMed |
| GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin. | Proc Natl Acad Sci U S A | 2023 | 37399373 | PubTator, text mining | PubMed |
| Association of the rs3864283 Polymorphism Located in the HINT1 Gene with Cigarette Use and Personality Traits. | Int J Mol Sci | 2023 | 37373392 | PubTator, text mining | PubMed |
| GPCR Binding and JNK3 Activation by Arrestin-3 Have Different Structural Requirements. | Cells | 2023 | 37371033 | PubTator, text mining | PubMed |
| Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors. | Membranes (Basel) | 2023 | 37367810 | PubTator, text mining | PubMed |
| Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model. | Mol Cell Proteomics | 2023 | 37348606 | PubTator, text mining | PubMed |
| Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. | J Clin Invest | 2023 | 37347559 | PubTator, text mining | PubMed |
| Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases. | Mediators Inflamm | 2023 | 37332618 | PubTator, text mining | PubMed |
| Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay. | Front Pharmacol | 2023 | 37324481 | PubTator, text mining | PubMed |
| Systematic and Comprehensive Analysis of tRNA-Derived Small RNAs Reveals Their Potential Regulatory Roles and Clinical Relevance in Sarcoidosis. | J Inflamm Res | 2023 | 37284703 | PubTator, text mining | PubMed |
| Visible-Light Photoswitchable Benzimidazole Azo-Arenes as β-Arrestin2-Biased Selective Cannabinoid 2 Receptor Agonists. | Angew Chem Int Ed Engl | 2023 | 37269130 | PubTator, text mining | PubMed |
| Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanoma. | Comput Biol Med | 2023 | 37267825 | PubTator, text mining | PubMed |
| Single-nucleus transcriptome analysis reveals transcriptional profiles of circadian clock and pain related genes in human and mouse trigeminal ganglion. | Front Neurosci | 2023 | 37250405 | PubTator, text mining | PubMed |
| Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief. | Proc Natl Acad Sci U S A | 2023 | 37216510 | PubTator, text mining | PubMed |
| Structural snapshots uncover a key phosphorylation motif in GPCRs driving β-arrestin activation. | Mol Cell | 2023 | 37209686 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=9